Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12570733 | Anti-betacellulin antibodies, fragments thereof, and multi-specific binding molecules | 🖼🧊📄§ | 2026-03-10 | 2042-06-30 | 0 | 31 |
| 12569512 | Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury | 🖼🧊📄§ | 2026-03-10 | 2042-05-13 | 0 | 31 |
| 12570735 | Compositions and methods for treating inflammasome related diseases or conditions | 🖼🧊📄§ | 2026-03-10 | 2039-07-03 | 0 | 31 |
| 12569557 | Targeting moDC to enhance vaccine efficacy on mucosal surface | 🖼🧊📄§ | 2026-03-10 | 2039-09-27 | 0 | 31 |
| 12570617 | Use of triazole compound as ghrelin receptor agonist | 🖼🧊📄§ | 2026-03-10 | 2041-09-17 | 0 | 31 |
| 12570608 | Compound derived from quinoline, use of a compound, composition and method for the treatment or prophylaxis of a condition caused by a blood parasite | 🖼🧊📄§ | 2026-03-10 | 2040-09-02 | 0 | 31 |
| 12570687 | Triterpenoid compounds, pharmaceutical compositions thereof, and their use for treating a nuclear receptor subfamily 4 group a member 1-mediated disease | 🖼🧊📄§ | 2026-03-10 | 2040-09-14 | 0 | 31 |
| 12569549 | Flavivirus vaccine | 🖼🧊📄§ | 2026-03-10 | 2044-01-04 | 0 | 31 |
| 12569521 | Methods and compositions for treating inflammatory skin disease with recombinant microorganisms | 🖼🧊📄§ | 2026-03-10 | 2044-04-22 | 0 | 31 |
| 12569561 | Double stranded oligonucleotide construct comprising androgen receptor specific sequence, and composition for preventing hair loss and promoting hair growth comprising same | 🖼🧊📄§ | 2026-03-10 | 2039-11-18 | 0 | 31 |
| 12569496 | Treatment of cancer with a RAF inhibitor | 🖼🧊📄§ | 2026-03-10 | 2044-01-26 | 0 | 31 |
| 12569459 | Compositions and methods for treating pulmonary edema or lung inflammation | 🖼🧊📄§ | 2026-03-10 | 2041-03-26 | 0 | 31 |
| 12570614 | Phenyl amino pyrimidine compounds and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-04-20 | 0 | 31 |
| 12569516 | Subject-specific tumor inhibiting cells and the use thereof | 🖼🧊📄§ | 2026-03-10 | 2043-08-17 | 0 | 31 |
| 12570754 | Regimens and methods of treating multiple sclerosis using ofatumumab | 🖼🧊📄§ | 2026-03-10 | 2043-06-08 | 0 | 31 |
| 12569439 | Bottom-up assembly of synthetic extracellular vesicles | 🖼🧊📄§ | 2026-03-10 | 2041-01-29 | 0 | 31 |
| 12569495 | Inhibitors of porcine reproductive and respiratory syndrome virus | 🖼🧊📄§ | 2026-03-10 | 2041-05-28 | 0 | 31 |
| 12570728 | Combinations of antibodies and bispecific antibodies comprising antigen-binding specifically recognizing Pseudomonas PcrV and Psl | 🖼🧊📄§ | 2026-03-10 | 2041-11-18 | 0 | 31 |
| 12570643 | 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-05-14 | 0 | 31 |
| 12570603 | FABP4/5 inhibitors, methods of use and methods of making | 🖼🧊📄§ | 2026-03-10 | 2042-09-14 | 0 | 31 |
| 12569478 | Sequestration compounds for treatment of substance use disorder and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2042-02-10 | 0 | 31 |
| 12569566 | Compositions containing, methods and uses of antibody-TLR agonist conjugates | 🖼🧊📄§ | 2026-03-10 | 2040-02-12 | 0 | 31 |
| 12569548 | RNA construct | 🖼🧊📄§ | 2026-03-10 | 2040-06-18 | 0 | 31 |
| 12570674 | Boron carrying agent for integrated tumor diagnosis and treatment, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-03-01 | 0 | 31 |
| 12570667 | Compounds with antibacterial and anti viral activities | 🖼🧊📄§ | 2026-03-10 | 2041-08-16 | 0 | 31 |
| 12571027 | Methods of associating genetic variants with a clinical outcome in patients suffering from age-related macular degeneration treated with anti-VEGF | 🖼🧊📄§ | 2026-03-10 | 2044-09-10 | 0 | 31 |
| 12570759 | Polypeptides | 🖼🧊📄§ | 2026-03-10 | 2039-12-17 | 0 | 31 |
| 12570648 | 6,7-dihydro-5H-pyrido[2,3-c]pyridazine derivatives and related compounds as Bcl-xL protein inhibitors and pro-apoptotic agents for treating cancer | 🖼🧊📄§ | 2026-03-10 | 2040-07-28 | 0 | 31 |
| 12570973 | Compositions and methods for inhibiting intermediate filament tetramerization | 🖼🧊📄§ | 2026-03-10 | 2039-10-08 | 0 | 31 |
| 12569525 | Gene therapy for treating phenylketonuria | 🖼🧊📄§ | 2026-03-10 | 2042-06-06 | 0 | 31 |
| 12570739 | Compositions and methods for improving health through modulating CALHM2 | 🖼🧊📄§ | 2026-03-10 | 2041-10-15 | 0 | 31 |
| 12569501 | Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions | 🖼🧊📄§ | 2026-03-10 | 2042-10-13 | 0 | 31 |
| 12569529 | Natural combination products and methods for regulation of kidney and excretory system function | 🖼🧊📄§ | 2026-03-10 | 2043-08-28 | 0 | 31 |
| 12569538 | DPEP-1 binding compositions and methods of use | 🖼🧊📄§ | 2026-03-10 | 2043-06-05 | 0 | 31 |
| 12570720 | Engineered receptors for human cytomegalovirus and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-15 | 0 | 31 |
| 12570652 | Pyrrolidine compound and use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-05-14 | 0 | 31 |
| 12571796 | Viral exposure signature for detection of early stage hepatocellular carcinoma | 🖼🧊📄§ | 2026-03-10 | 2040-10-09 | 0 | 31 |
| 12569517 | Method for treating osteoarthritis with mesenchymal stem cell exosomes | 🖼🧊📄§ | 2026-03-10 | 2040-02-07 | 0 | 31 |
| 12569560 | Bismuth-gadolinium nanoparticles | 🖼🧊📄§ | 2026-03-10 | 2043-01-24 | 0 | 31 |
| 12570719 | Chimeric antigen receptor comprising anti c-met antibody or antigen binding fragment thereof, and use thereof | 🖼🧊📄§ | 2026-03-10 | 2040-09-25 | 0 | 31 |
| 12569547 | Immunogenic compositions against Clostridioides (Clostridium) difficile and methods thereof | 🖼🧊📄§ | 2026-03-10 | 2041-06-17 | 0 | 31 |
| 12569465 | Method for activating follicles by means of using small-molecule compound, and preparation thereof | 🖼🧊📄§ | 2026-03-10 | 2041-07-08 | 0 | 31 |
| 12570712 | Cyclin A1 specific T cell receptors and uses thereof | 🖼🧊📄§ | 2026-03-10 | 2039-02-12 | 0 | 31 |
| 12570597 | Polyaryl carboxylic fullerene derivative and use thereof in anti-coronavirus infection | 🖼🧊📄§ | 2026-03-10 | 2041-08-09 | 0 | 31 |
| 12569486 | Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies | 🖼🧊📄§ | 2026-03-10 | 2044-02-13 | 0 | 31 |
| 12569559 | Engineered dendritic cell and use thereof | 🖼🧊📄§ | 2026-03-10 | 2045-01-18 | 0 | 31 |
| 12570689 | Purification of GLP-1 analogues | 🖼🧊📄§ | 2026-03-10 | 2040-02-05 | 0 | 31 |
| 12570628 | Salts of obicetrapib and processes for their manufacture and intermediates thereof | 🖼🧊📄§ | 2026-03-10 | 2045-04-14 | 0 | 31 |
| 12569527 | Tetraselmis chuii (T. chuii) for the treatment of male infertility | 🖼🧊📄§ | 2026-03-10 | 2041-07-09 | 0 | 31 |
| 12570639 | Tetrahydroquinoline derivative and medicinal use thereof | 🖼🧊📄§ | 2026-03-10 | 2041-12-24 | 0 | 31 |